Insights

Growth in Healthcare Chiesi UK has demonstrated significant expansion since its establishment in 1999, with a workforce of around 400 employees and ongoing investment in research and development facilities. This indicates a capacity for further growth and a potential need for advanced healthcare solutions, medical supplies, and collaborative research partnerships.

Innovation Focus As a research-focused biopharmaceutical company developing therapies for chronic and genetic diseases, Chiesi prioritizes innovative therapeutic solutions. This creates opportunities to introduce cutting-edge technologies, specialized medical devices, and advanced pharmaceutical ingredients to support their R&D and product offerings.

Sustainability Commitment Chiesi’s ambition to become a Net Zero company by 2035 and its status as a B Corp reflect a strong sustainability agenda. Suppliers and service providers with eco-friendly, sustainable products and practices could align well with their corporate values, opening doors for green solutions and environmentally responsible partnerships.

Market Expansion Potential Operating in over 100 countries with a focus on respiratory health, rare diseases, and specialty care positions Chiesi as a potential partner for market entry strategies in expanded territories or for specialized distribution channels, offering opportunities for regional distributors, logistics providers, and market access services.

Recognition as an Employer Being recognized as a top employer and achieving top 25 World’s Best Workplaces indicates a strong corporate culture and robust talent management. Engaging in workforce training, HR technology, or employee engagement solutions could support Chiesi’s ongoing efforts to attract and retain top talent globally.

Chiesi UK Tech Stack

Chiesi UK uses 8 technology products and services including cdnjs, Font Awesome, jQuery, and more. Explore Chiesi UK's tech stack below.

  • cdnjs
    Content Delivery Network
  • Font Awesome
    Font Scripts
  • jQuery
    Javascript Libraries
  • Polyfill
    Javascript Libraries
  • PHP
    Programming Languages
  • X-Content-Type-Options
    Web & Portal Technology
  • Apache
    Web Servers
  • Facebook
    Widgets

Media & News

Chiesi UK's Email Address Formats

Chiesi UK uses at least 1 format(s):
Chiesi UK Email FormatsExamplePercentage
FLast@chiesi.uk.comJDoe@chiesi.uk.com
49%
Last@chiesi.uk.comDoe@chiesi.uk.com
1%
LFirst@chiesi.uk.comDJohn@chiesi.uk.com
1%
FLast@chiesi.uk.comJDoe@chiesi.uk.com
49%

Frequently Asked Questions

What is Chiesi UK's official website and social media links?

Minus sign iconPlus sign icon
Chiesi UK's official website is chiesi.uk.com and has social profiles on LinkedIn.

What is Chiesi UK's SIC code NAICS code?

Minus sign iconPlus sign icon
Chiesi UK's SIC code is 2834 - Pharmaceutical Preparations NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Chiesi UK have currently?

Minus sign iconPlus sign icon
As of December 2025, Chiesi UK has approximately 271 employees across 2 continents, including EuropeAsia. Key team members include Vice President Business Unit Air: K. H.Head Of Crm & Customer Insight, Uk: L. N.Head Of Market Access: R. S.. Explore Chiesi UK's employee directory with LeadIQ.

What industry does Chiesi UK belong to?

Minus sign iconPlus sign icon
Chiesi UK operates in the Pharmaceutical Manufacturing industry.

What technology does Chiesi UK use?

Minus sign iconPlus sign icon
Chiesi UK's tech stack includes cdnjsFont AwesomejQueryPolyfillPHPX-Content-Type-OptionsApacheFacebook.

What is Chiesi UK's email format?

Minus sign iconPlus sign icon
Chiesi UK's email format typically follows the pattern of FLast@chiesi.uk.com. Find more Chiesi UK email formats with LeadIQ.

When was Chiesi UK founded?

Minus sign iconPlus sign icon
Chiesi UK was founded in 1999.

Chiesi UK

Pharmaceutical ManufacturingEngland, United Kingdom201-500 Employees

Chiesi is a research-focused biopharmaceuticals group that develops and markets innovative therapeutic solutions for chronic and genetic diseases. Working across respiratory health, rare diseases and speciality care, our medicines are delivered to patients in over 100 countries worldwide. 

We are driven by the concept of shared value; making decisions based on what is best for our business, the planet, patients, and people. As a B Corp, we’re part of a global community of businesses that meet high standards of social and environmental impact, and we have an ambitious yet robust plan to become a Net Zero company by 2035.

Our UK business was established in 1999 and has grown to a team of around 400 people based in our head office in Manchester, a research and development centre in Chippenham and a network of field-based teams. 

Our people are our greatest strength, and our workplace is purposeful, equitable, and diverse. We are proud to have been recognised year after year as an outstanding employer, receiving numerous accolades from internationally recognised authorities such as Great Place to Work®. In 2024, we were named within the top 25 World’s Best Workplaces™ – the first time any European pharmaceutical company has achieved this ranking. 

Community guidelines: https://lnkd.in/e4pPzSKJ

Section iconCompany Overview

SIC Code
2834 - Pharmaceutical Preparations
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Founded
1999
Employees
201-500

Section iconMedia & News

Section iconFunding & Financials

  • $10M$25M

    Chiesi UK's revenue is estimated to be in the range of $10M$25M

Section iconFunding & Financials

  • $10M$25M

    Chiesi UK's revenue is estimated to be in the range of $10M$25M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.